| Structure |
Chemical Name |
CAS |
MF |
 |
Abiraterone Impurity 9 |
165334-72-5 |
C24H31NO |
![(1S)-N-(3S)-1-アザビシクロ[2.2.2]オクト-3-イル-1,2,3,4-テトラヒドロ-1-ナフタレンカルボキサミド](/CAS/GIF/177793-79-2.gif) |
(1S)-N-(3S)-1-アザビシクロ[2.2.2]オクト-3-イル-1,2,3,4-テトラヒドロ-1-ナフタレンカルボキサミド |
177793-79-2 |
C18H24N2O |
 |
Cyclopropane, nitroso- |
28017-92-7 |
C3H5NO |
![2-Propanone, 1-[4,5-dihydro-2-(4-methyl-1-piperazinyl)-4-thioxo-3H-1,5-benzodiazepin-3-ylidene]-](/CAS/20200611/GIF/1902955-67-2.gif) |
2-Propanone, 1-[4,5-dihydro-2-(4-methyl-1-piperazinyl)-4-thioxo-3H-1,5-benzodiazepin-3-ylidene]- |
1902955-67-2 |
C17H20N4OS |
 |
Butyphthalide impurity 30 |
|
|
![(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid hydrochloride](/CAS/20150408/GIF/1038924-71-8.gif) |
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid hydrochloride |
1038924-71-8 |
C18H22ClNO2 |
 |
Pemetrexed |
|
|
 |
Dapoxetine impurity 54 |
|
|
 |
Carvedilol Impurity NH |
|
|
![EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2S,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]-](/CAS/GIF/1255529-28-2.gif) |
EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2S,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]- |
1255529-28-2 |
C24H30ClN7O4S |
 |
Deoxy Fesoterodine |
895137-81-2 |
C26H37NO2 |
 |
(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)-L-cysteine |
2238849-52-8 |
C13H15N3O3S |
 |
Donepezil Impurity |
36159-03-2 |
C22H22O5 |
![8-(2,3-dichlorophenyl)-5,8-diazaspiro[4.5]decan-5-ium bromide](/CAS/20211123/GIF/2043655-58-7.gif) |
8-(2,3-dichlorophenyl)-5,8-diazaspiro[4.5]decan-5-ium bromide |
2043655-58-7 |
C14H19Cl3N2 |
 |
Baricitinib Impurity 5 |
|
|
![1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-(hydroxyMethyl)-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-,(βR)-](/CAS/20180808/GIF/1236033-03-6.gif) |
1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-(hydroxyMethyl)-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-,(βR)- |
1236033-03-6 |
C18H20N6O |
 |
Cefoxitin Sodium impurity |
|
|
 |
(E)-2-hydroxy-4-(phenyldiazenyl)benzoic acid |
40038-46-8 |
C13H10N2O3 |
 |
Vardenafil IMpurity 3 |
1255919-01-7 |
C26H30N6O4S |
 |
4-(3-nitrophenyl)-3-Morpholinone |
845729-43-3 |
C10H10N2O4 |
 |
Latanoprost Impurity 3 |
2278245-92-2 |
C27H41BrO5 |
 |
Canagliflozin Impurity 32 |
|
|
 |
(1R,4R)-1-(メチルアミノ)-4-(3,4-ジクロロフェニル)テトラリン |
79617-95-1 |
C17H17Cl2N |
 |
5-ヒドロキシ-6-メトキシ-1-インダノン |
127399-78-4 |
C10H10O3 |
 |
2,4-ジメチルジフェニルスルフィド, IN ISOOCTANE (500ΜG/ML) |
16704-47-5 |
C14H14S |
 |
Lercanidipine Impurity 25 |
100427-22-3 |
C36H41N3O6 |
 |
ソラフェニブN-オキシド |
583840-03-3 |
C21H16ClF3N4O4 |
 |
(S)-dimethyl 2-(4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioate |
67676-60-2 |
C22H27ClN8O5 |
![1-[4-(2-Methoxyethenyl)phenoxy]-3-[(1-Methylethyl)aMino]-2-propanol](/CAS/20150408/GIF/82961-02-2.gif) |
1-[4-(2-Methoxyethenyl)phenoxy]-3-[(1-Methylethyl)aMino]-2-propanol |
82961-02-2 |
C15H23NO3 |
 |
Ozagrel Impurity 3 |
|
|
 |
Flurbiprofen IMpurity E |
|
|
 |
Juncusol 7-O-glucoside |
175094-15-2 |
C24H28O7 |
 |
Lamivudine Impurity 1 |
1235712-40-9 |
C8H11N3O4S |
 |
(1R,3aR,7aR)-7a-Methyl-1-((R)-6-Methylheptan-2-yl)hexahydro-1H-inden-4(2H)-one |
66251-18-1 |
C18H32O |
 |
5-メチル-3-フェニルイソオキサゾール-4-カルボン酸 |
1136-45-4 |
C11H9NO3 |
 |
メロシドA |
60767-80-8 |
C27H30O15 |
![1-デオキシ-1-[[3,4-ジメチル-2-(フェニルアゾ)フェニル]アミノ]-D-リビトール](/CAS/20200611/GIF/21037-25-2.gif) |
1-デオキシ-1-[[3,4-ジメチル-2-(フェニルアゾ)フェニル]アミノ]-D-リビトール |
21037-25-2 |
C19H25N3O4 |
 |
Metronidazole IMpurity D |
|
|
 |
Empagliflozin Impurity 79 |
|
|
 |
4-bromo-2-nitropyridine |
909712-10-3 |
C5H3BrN2O2 |
 |
Cephalexin Impurity 3 |
|
C16H17N3O4S |
 |
4,5-Dihydro-α,3-diMethyl-5-oxo-1-phenyl-α-sulfo-1H-pyrazole-4-acetic Acid |
1357477-99-6 |
C13H14N2O6S |
 |
Levothyroxine Sodium impurity |
27566-09-2 |
C14H21NO4 |
 |
Vildagliptin Impurity 34 |
1824265-77-1 |
C10H17NO3 |
 |
Ticagrelor Impurity 69 |
|
|
![(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-diMethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester (2Z)-2-Methyl-2-butenoic Acid](/CAS/GIF/1048973-04-1.gif) |
(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-diMethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester (2Z)-2-Methyl-2-butenoic Acid |
1048973-04-1 |
C24H34O5 |
 |
Sulpiride IMpurity F |
|
|
 |
Cefminox Impurity D |
|
|
 |
trans-アポビンカミン酸エチル |
77549-94-1 |
C22H26N2O2 |
 |
(3S,3'S,4R,4'R)-3,3'-(oxybis(methylene))bis(4-(4-fluorophenyl)-1- methylpiperidine) |
|
C26H34F2N2O |
 |
Empagliflozin (R)-Isomer |
864070-43-9 |
C23H27ClO7 |
 |
Tafluprost Impurity 13 |
|
|
 |
Isavuconazole Impurity 3 |
|
|
 |
AtracuriuM IMpurity D2 (cis-Quaternary Alcohol) |
1100676-16-1 |
C35H47NO10S |
![3-(6,7-Dihydro-2-Methyl-7-oxo-3-propyl-2H-pyrazolo[4,3-d]pyriMidin-5-yl)-4-ethoxy-benzenesulfonyl Chloride](/CAS/GIF/501120-42-9.gif) |
3-(6,7-Dihydro-2-Methyl-7-oxo-3-propyl-2H-pyrazolo[4,3-d]pyriMidin-5-yl)-4-ethoxy-benzenesulfonyl Chloride |
501120-42-9 |
C17H19ClN4O4S |
 |
Ticagrelor Impurity 131 |
|
|
 |
Cefditoren Impurity 1 |
|
|
 |
Olprinone Impurity 7 |
2236020-10-1 |
C9H10N2 |
 |
S 00218 |
92700-82-8 |
C15H22N2O4 |
 |
Sodium chloride standard titration solution c(NaCl)=0.1 mol/L |
|
|
 |
Everolimus Impurity 2 |
|
|
 |
Dabrafenib Impurity 1 |
1907654-22-1 |
C24H21F3N4O3S2 |
 |
デクラジノースロキシスロマイシン (ROXITHROMロキシトロマイシン不純物B |
214902-82-6 |
C33H62N2O12 |
 |
Sacubitril Impurity 72 |
1361408-16-3 |
C23H27NO4 |
 |
Des(trifluoroethyl) Lansoprazole Sulfide |
131926-97-1 |
C14H13N3OS |
 |
HYDRIDE-L |
41639-74-1 |
C18H22O4 |
 |
Olaparib Impurity F |
|
|
 |
Oxacillin sodium EP impurity B |
|
|
 |
Parecoxib Sodium Impurity 14 |
1709956-89-7 |
C19H18N2O4S |
 |
Miglitol Isomer impurities C |
|
|
 |
Iopamidol Impurity K |
1788899-70-6 |
C17H23I2N3O8 |
![3,5-Pyridinedicarboxylic acid, 2-[(2-chloroethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester](/CAS/20210305/GIF/221446-45-3.gif) |
3,5-Pyridinedicarboxylic acid, 2-[(2-chloroethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester |
221446-45-3 |
C20H23Cl2NO5 |
 |
Defluoro Paroxetine Hydrochloride |
1394842-91-1 |
|
 |
Saxagliptin Impurity 9 |
|
|
 |
(5-Ethyl-1H-imidazol-4-yl)methanol |
38603-74-6 |
C6H10N2O |
 |
N-Ethyl-3-buteno-o-toluidide |
13936-71-5 |
C13H17NO |
 |
Afatinib IMpurity I |
1637254-93-3 |
C22H19BrClFN4O3 |
 |
Paclitaxel Impurity1 ABCDEFGHJKL |
|
|
 |
Aprepitant iMpurity 37 |
|
|
 |
Ferrous tartrate solution c(FeSO4)=1 g/L,c(C4H4O6KNa)=5 g/L |
|
|
 |
4-O-(カルボキシメチル)リファマイシン |
13929-35-6 |
C39H49NO14 |
 |
ドキシルアミン4-ピリジニル異性体 |
873407-01-3 |
C17H22N2O |
 |
AvatrombopagImpurity42 |
|
|
 |
Etoricoxib iMpurity 2 |
|
|
 |
SofosBuvir Impurity 55 |
|
|
 |
4-Methoxy-3,5-diMethylpyridine 1-Oxide |
91219-89-5 |
C8H11NO2 |
 |
(S,E)-3-(2,6-dichloro-4-((4-(3-(1-(hexyloxy)ethyl)-2-hydroxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylic acid |
|
|
![Tricyclo[3.3.1.13,7]decane-1,3-diol, 5-amino-](/CAS/20200611/GIF/1382839-19-1.gif) |
Tricyclo[3.3.1.13,7]decane-1,3-diol, 5-amino- |
1382839-19-1 |
C10H17NO2 |
 |
(2R,3R,4R,5S,6R)-2-(4-chloro-3-(4-(((R)-tetrahydrofuran- 3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H- pyran-3,4,5-triol |
|
C23H27ClO7 |
 |
Aprepitant Impurity 53 |
|
|
 |
tert-butyl (3R,5R)-7-(1-((3R,5R)-7-(tert-butoxy)-3,5-dihydroxy-7-oxoheptyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxamido)-3,5-dihydroxyheptanoate |
|
|
 |
1-エチル-4-オキソ-6-クロロ-7-(1-ピペラジニル)-1,4-ジヒドロ-3-キノリンカルボン酸 |
67681-84-9 |
C16H18ClN3O3 |
 |
Cefathiamidine Impurity D |
|
|
 |
Ibrutinib Impurity 11 |
|
C27H31N7O2 |
![(1R,3S)-1-(1,3-ベンゾジオキソール-5-イル)-2-(2-クロロアセチル)-2,3,4,9-テトラヒドロ-1H-ピリド[3,4-B]インドール-3-カルボン酸メチルエステル](/CAS/GIF/629652-44-4.gif) |
(1R,3S)-1-(1,3-ベンゾジオキソール-5-イル)-2-(2-クロロアセチル)-2,3,4,9-テトラヒドロ-1H-ピリド[3,4-B]インドール-3-カルボン酸メチルエステル |
629652-44-4 |
C22H19ClN2O5 |
 |
7-Bromo Epinastine |
1217052-16-8 |
C16H14BrN3 |
![[1,1'-Biphenyl]-3,3'-dicarboxamide, 6,6'-diamino-5-chloro-N3,N3'-bis[2-(diethylamino)ethyl]-2,4'-dimethoxy-](/CAS/20210305/GIF/1242047-99-9.gif) |
[1,1'-Biphenyl]-3,3'-dicarboxamide, 6,6'-diamino-5-chloro-N3,N3'-bis[2-(diethylamino)ethyl]-2,4'-dimethoxy- |
1242047-99-9 |
C28H43ClN6O4 |
 |
Cefoxitin impurity E |
2395025-32-6 |
C17H19N3O8S2 |
 |
(1R,3S)-Solifenacin Succinate |
774517-20-3 |
C23H26N2O2 |
 |
Ornidazole Impurity 15 |
105687-87-4 |
C7H9ClN4O5 |